Autonomix Medical, Inc. (NASDAQ:AMIX) Short Interest Down 26.4% in October

Autonomix Medical, Inc. (NASDAQ:AMIX) saw a significant decrease in short interest during the month of October. As of October 31st, there was short interest totalling 100,200 shares, a decrease of 26.4% from the October 15th total of 136,100 shares. Approximately 16.0% of the shares of the stock are sold short. Based on an average daily volume of 472,700 shares, the short-interest ratio is currently 0.2 days.

Analyst Upgrades and Downgrades

Separately, LADENBURG THALM/SH SH initiated coverage on shares of Autonomix Medical in a research report on Tuesday, September 3rd. They set a “buy” rating and a $28.00 target price for the company.

Autonomix Medical Stock Performance

Shares of NASDAQ AMIX traded up $0.12 during trading hours on Friday, reaching $9.69. 13,767 shares of the stock were exchanged, compared to its average volume of 225,310. Autonomix Medical has a 52 week low of $7.51 and a 52 week high of $152.00. The company has a debt-to-equity ratio of 0.36, a quick ratio of 9.27 and a current ratio of 4.26. The firm has a market capitalization of $11.14 million and a price-to-earnings ratio of -0.61. The stock’s fifty day simple moving average is $12.29 and its 200 day simple moving average is $22.85.

Autonomix Medical (NASDAQ:AMIX) last announced its quarterly earnings data on Tuesday, August 13th. The company reported ($2.80) earnings per share for the quarter. Sell-side analysts predict that Autonomix Medical will post -10 EPS for the current year.

About Autonomix Medical

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals.